Quality accreditation
We know that the work you are doing will ultimately change the world for the better, so we want you to have the highest level of trust and confidence in our products and services.
Commitment to quality
We deliver ground-breaking solutions that will help our customers advance the future of precision medicine. The patient is our priority, and we strive to provide testing that has a meaningful impact on an individual’s healthcare experience and outcomes. A commitment to maintaining the highest quality standards for all our products and clinical services is core to this.
Accreditation
Confidence in our Clinical Services
ISO 15189:2022
Nonacus Clinical Services offer UKAS accredited Hereditary Cancer services, to ISO 15189:2022 standard, giving you complete confidence in our results, team and processes. All our services adhere to these strict quality guidelines.
Products you can rely on
ISO 13485
Nonacus has a certified Quality Management System based on the standard ISO 13485:2016 covering the design, development and servicing of our products to ensure we deliver quality and continuous improvement.
Safeguarding your data
ISO 27001
Nonacus has implemented ISO/IEC 27001:2022, the international standard for information security management systems (ISMS) to maintain the highest standards of information security and protect the sensitive data of our customers
Our Quality Leads
Bruno Ping, Chief Operations Officer at Nonacus
“Quality is a critical factor in manufacturing and something our customers expect us to deliver. Our quality management system operating to ISO standards is in place to ensure that we do just that. The result is products that our customers can rely on, time after time."
Estelle Willliams, Quality Manager at Informed Genomics, trading as Nonacus Clinical Services
“We are focused on quality and maintaining the highest standards of work – we process samples with a level of care that patients expect and want. I’m proud to be part of this dedicated and hard-working team and the results that we deliver.”
Victoria Hewitt, Clinical Laboratory Director at Nonacus Clinical Services
“We are a trusted provider of UKAS-accredited clinical services to NHS Trusts and private healthcare providers across the UK; a position only possible if we adhere to the strictest of quality standards. We are proud of and passionate about the delivery of our high-quality standards, providing consistent, rapid and accurate results that our customers and their patients can trust”.
Hereditary Cancer Services – further information
Informed Genomics Limited (IGL), trading as Nonacus Clinical Services (NCS), is committed to the provision of a high quality, efficient, accurate and responsive analytical, diagnostic and advisory service. NCS will evolve, develop, and continue to offer a professional service which meets the needs and requirements of all its users.
It is the policy of NCS to maintain and manage an integrated and effective Management System (MS). The MS shall integrate the company’s procedures, processes and resources and will be monitored and reviewed on a continual basis whilst ensuring continual quality improvement is adhered to in accordance with the requirements of ISO 15189:2022 (UKAS reference number: 22262).
NCS is committed to user satisfaction and the main goals of the company are:
- To comply with the ISO 15189:2022 standard whilst committing to good professional practice and conduct.
- To establish, monitor and review the company measurable quality objectives.
- To promote quality throughout the business and ensure all personnel are familiar with the quality policy, the MS and all associated procedures.
- To ensure personnel are familiar with the roles and responsibilities of each department and individual within the company MS.
- To operate a healthy and safe working environment for staff and visitors, complying with statutory environmental, health and safety regulations.
- To identify and work with suppliers and partners who maintain a high level of quality assurance.
- To recruit, train, retain and develop all staff of all levels to achieve the standards required to provide a full and effective service to users.
- To procure and effectively maintain equipment and other resources needed for the provision of the service.
- To correctly handle specimens to ensure the correct performance of laboratory examinations.
- To report results of examinations in a timely, confidential, accurate and clinically useful manner.
- To ensure new and existing examination procedures are fit for purpose.
- To perform regular audits of our internal processes.
- To undertake all company activities impartially as NCS is committed to unbiased practices.
- To use internal and external quality assessment and participation in appropriate regional and national external quality assessment schemes (e.g., GENQA) as this reinforces impartiality and competence.
- To have a greater focus on clinical risk and impact on end user care.
NCS welcomes all feedback as it enables us to continually improve the services we offer. All feedback can be sent to clinical@nonacus.com or alternatively please use the Contact Us form on this website.
NCS places service quality and patient satisfaction at the forefront of all our processes and is committed to continual learning and improvement of our services. If you need to raise a complaint please contact Estelle Williams, Quality Manager or Victoria Hewitt, Clinical Laboratory Director at clinical@nonacus.com Alternatively, please use the Contact Us form on this website. All information will be treated as confidential and will be addressed using our internal complaints procedure.
NCS is committed to investigating all complaints thoroughly with a view to obtaining a quick and effective resolution that also ensures that any lessons identified are embedded throughout the company.
NCS will acknowledge the receipt of all complaints within five working days and will perform a root cause investigation and respond to all complaints within 30 working days, outlining any findings along with any corrective actions that will be implemented. In cases where a full investigation has been unable to be completed within the 30-working day timeframe, all complainants will be written to, providing a reason for the delay in a complete response and a new timeframe for completing the investigation. If you are not happy with the outcome of your complaint, you will be advised on the next steps to take.
